# Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis

> **NCT00690911** · PHASE2 · WITHDRAWN · sponsor: **Wake Forest University**

## Conditions studied

- Sarcoidosis

## Interventions

- **DRUG:** adalimumab

## Key facts

- **NCT ID:** NCT00690911
- **Lead sponsor:** Wake Forest University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Dr. Jorizzo has decided to withdraw from this study due to the time it is taking to get the study started.
- **Last updated:** 2017-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00690911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00690911, "Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00690911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*